Immunologic assessments from ARTEMIS: A European, phase 3, randomized, double-blind, placebo-controlled trial of AR101 in peanut-allergic subjects aged 4–17 years
Titel:
Immunologic assessments from ARTEMIS: A European, phase 3, randomized, double-blind, placebo-controlled trial of AR101 in peanut-allergic subjects aged 4–17 years
Auteur:
Delebarre Sauvage, C. Nilsson, C. Beyer, K. Fernández-Rivas, M. du Toit, G. Turner, P.J. Blümchen, K. Dolores Ibáñez, M. Deschildre, A. Muraro, A. Sharma, V. Erlewyn-Lajeunesse, M. Manuel Zubeldia, J. De Blay, F. Byrne, A. Chapman, J. Boralevi, F. Hylands, K. Norval, D. Abbas, A. Hourihane, J.O.B.